Merck & Co., Inc. (NYSE:MRK)

Big Pharma Has Big Catalysts Coming for the Rest of 2017

The big pharmaceutical stocks are one area that has done somewhat better this year. One major reason for that is the shrill rhetoric from politicians has quieted as the election ...
Read Full Story »

Major Pharma Short Interest Surges

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

What to Expect From Merck at ASCO

The premier event for biotech and pharma companies in 2017 is just around the corner. The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) is set to ...
Read Full Story »

Wal-Mart, Apple Lead DJIA Higher Thursday

May 18, 2017: Markets opened lower again Thursday as investors and traders still seemed jittery over developments in Washington. By midday all three major indexes traded in the green led ...
Read Full Story »

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse analyst Vamil Divan has released an outlook on the pharmaceutical sector. While the weighting for the sector is Market Weight, there are some positives in the call. The ...
Read Full Story »

General Electric, Merck Lead Drop in DJIA Friday

May 12, 2017: Markets opened mixed Friday following lackluster earnings results from two more retailers, Penney's and Nordstrom. Investors are also concerned that the turmoil in the Trump administration will ...
Read Full Story »

Why Big Pharma Is Not at Fault for Record Drug Spending

With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it as the industry punching bag. But the truth is, Big ...
Read Full Story »

Merck’s Accelerated Keytruda Lung Cancer Approval Creates 3 Moves

It is no secret that pharma and biotech shares have had to deal with at least some headwinds over the past year. It turns out that drug pricing concerns and ...
Read Full Story »

Short Interest in Major Pharma Shrinks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Chevron, Merck Sink DJIA on Tuesday

May 9, 2017: Markets opened higher Tuesday but only the Nasdaq composite traded in the green for the whole day. Consumer discretionary, industrial, and tech stocks traded higher while energy ...
Read Full Story »

DuPont, Apple Drive DJIA Higher on Friday

May 5, 2017: Markets opened higher Thursday but the blue chippers dropped into negative territory quickly and stayed there until the afternoon. The report on non-farm payrolls while the unemployment ...
Read Full Story »

Chevron, Merck Lift DJIA Wednesday

May 3, 2017: Markets opened lower Wednesday and only the blue-chippers were able to cross, however tentatively, into positive territory. The only S&P sectors heading for gains today are energy, ...
Read Full Story »

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results on Tuesday. Most of the companies in the Dow ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »